16th Nov 2006 13:00
Sinclair Pharma PLC16 November 2006 Sinclair Pharma plc presenting at Piper Jaffray Annual Global Healthcare Conference 16 November 2006, Godalming, UK - Sinclair Pharma plc (AIM: SPH.L), theinternational specialty pharmaceutical company today announces that its ChiefExecutive Officer, Dr Michael Flynn, and Chief Financial Officer Jerry Randall,will be presenting at the Piper Jaffray Health Care Conference at the PierreHotel, New York, on Wednesday 29th November at 3.30pm. A live webcast of Sinclair's presentation will be available at http://www.piperjaffray.com/hcwebcast. The presentation and further companyinformation will also be available at www.sinclairpharma.com. Sinclair Pharma plc Sinclair Pharma plc is an international specialty pharmaceutical company. Ithas a growing sales and marketing operation that is already present in France,Italy, the UK, Spain and Portugal, and a complementary marketing partner networkthat spans 60 countries. Sinclair has proven expertise in acquiring or developing commercially attractiveand undervalued products, registering these products and bringing them to marketwithin a short time frame. The company focuses on niche therapeutic areas andits current portfolio includes products for dermatological conditions and oralhealth. Enquiries: Sinclair Pharma plc Tel: +44 1483 410 600Zoe McDougall +44 7973 792 520 John Barrington-Carver Tel: +44 7831 655 630Sinclair US Mike Killeen Tel +1 972 478 4380 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Sinclair Pharma